← Back to Search

Behavioural Intervention

Music-Enhanced Exercise for Seniors (iSTEP Trial)

N/A
Recruiting
Led By Jennifer L Etnier, PhD
Research Sponsored by University of North Carolina, Greensboro
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up will be reported daily from the first day of the intervention to the last day of the intervention (6 months)
Awards & highlights

Summary

This trial aims to see if listening to music with a beat can help older adults become more active. The study will look at whether this type of music can positively affect their physical activity levels and how they

Who is the study for?
This trial is for cognitively normal older adults who are interested in improving their physical activity. Participants will engage in supervised group strength and aerobic exercises, with some sessions incorporating beat-accented music stimulation (BMS).Check my eligibility
What is being tested?
The study aims to see if BMS can positively affect exercise behavior and psychological responses over a 6-month period. It also looks at how exercising with BMS might impact physical and cognitive functions, as well as quality of life.See study design
What are the potential side effects?
Since the interventions involve music and exercise, side effects may include typical exercise-related issues such as muscle soreness or strain. No significant side effects from listening to music are expected.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~will be reported daily from the first day of the intervention to the last day of the intervention (6 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and will be reported daily from the first day of the intervention to the last day of the intervention (6 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Ecological Momentary Assessment (EMA): Affective response to PA
Ecological Momentary Assessment (EMA): Anticipated, remembered, and incidental affect
Ecological Momentary Assessment (EMA): Behavioral intention
+6 more
Secondary outcome measures
10-Meter Walk
30-second Chair Stand
4-Stage Balance Test
+20 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Exercise and music stimulationExperimental Treatment2 Interventions
Participants are given an aerobic and strength training program with faded supervision across 6 months. For aerobic exercise (AE), participants will be instructed to walk at moderate intensity with duration increasing up to an ultimate goal of 150 min/week. Participants will be trained to walk in synchrony with the beats of their personalized playlists. The strength training (ST) incorporates single-leg exercises for balance training and training with resistance bands and body weight. During the ST, participants will be asked to synchronize their concentric and eccentric muscle contractions in time with the tempo of BMS playlists at a specific beats-per-minute rhythm.
Group II: Exercise onlyActive Control1 Intervention
Participants are given an aerobic and strength training program with faded supervision across 6 months. The ST incorporates single-leg exercises for balance training and training with resistance bands and body weight. For aerobic exercise (AE), participants will be instructed to walk at moderate intensity with duration increasing up to an ultimate goal of 150 min/week.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Music
2013
Completed Phase 3
~1810
Exercise
2016
Completed Phase 1
~760

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,704 Previous Clinical Trials
28,033,207 Total Patients Enrolled
3 Trials studying Cognitively Normal Older Adults
853 Patients Enrolled for Cognitively Normal Older Adults
University of North Carolina, GreensboroLead Sponsor
31 Previous Clinical Trials
16,591 Total Patients Enrolled
Jennifer L Etnier, PhDPrincipal InvestigatorUniversity of North Carolina, Greensboro
~33 spots leftby Apr 2025